239 related articles for article (PubMed ID: 35740335)
21. Relative Risk of Peripheral Neuropathy With Ado-Trastuzumab Emtansine (T-DM1) Compared to Taxane-Based Regimens in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Cancers: A Systematic Review and Meta-Analysis.
Jahan N; Rehman S; Khan R; Jones C
Cureus; 2021 May; 13(5):e15282. PubMed ID: 34194883
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of endocrine therapy resistance in breast cancer.
Rasha F; Sharma M; Pruitt K
Mol Cell Endocrinol; 2021 Jul; 532():111322. PubMed ID: 34000350
[TBL] [Abstract][Full Text] [Related]
23. Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment.
Molehin D; Filleur S; Pruitt K
Mol Cell Endocrinol; 2021 Jul; 531():111321. PubMed ID: 33992735
[TBL] [Abstract][Full Text] [Related]
24. Endocrine prevention of breast cancer.
Jahan N; Jones C; Rahman RL
Mol Cell Endocrinol; 2021 Jun; 530():111284. PubMed ID: 33882282
[TBL] [Abstract][Full Text] [Related]
25. Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth.
Castro-Piedras I; Sharma M; Brelsfoard J; Vartak D; Martinez EG; Rivera C; Molehin D; Bright RK; Fokar M; Guindon J; Pruitt K
EMBO Rep; 2021 Jun; 22(6):e50600. PubMed ID: 33860601
[TBL] [Abstract][Full Text] [Related]
26. Regulation of aromatase in cancer.
Molehin D; Rasha F; Rahman RL; Pruitt K
Mol Cell Biochem; 2021 Jun; 476(6):2449-2464. PubMed ID: 33599895
[TBL] [Abstract][Full Text] [Related]
27. Aging in COVID-19: Vulnerability, immunity and intervention.
Chen Y; Klein SL; Garibaldi BT; Li H; Wu C; Osevala NM; Li T; Margolick JB; Pawelec G; Leng SX
Ageing Res Rev; 2021 Jan; 65():101205. PubMed ID: 33137510
[TBL] [Abstract][Full Text] [Related]
28. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
29. Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators.
Gómez-Coronado D; Lasunción MA; Martínez-Botas J; Fernández-Suárez ME
Semin Cancer Biol; 2021 Aug; 73():101-115. PubMed ID: 32931953
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast Cancer.
Abderrahman B; Maximov PY; Curpan RF; Hanspal JS; Fan P; Xiong R; Tonetti DA; Thatcher GRJ; Jordan VC
Mol Pharmacol; 2020 Oct; 98(4):364-381. PubMed ID: 32788222
[TBL] [Abstract][Full Text] [Related]
31. The 5,6-epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets.
de Medina P; Diallo K; Huc-Claustre E; Attia M; Soulès R; Silvente-Poirot S; Poirot M
Br J Pharmacol; 2021 Aug; 178(16):3248-3260. PubMed ID: 32696532
[TBL] [Abstract][Full Text] [Related]
32. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages.
Amjad E; Asnaashari S; Sokouti B; Dastmalchi S
Sci Rep; 2020 Jul; 10(1):10816. PubMed ID: 32616754
[TBL] [Abstract][Full Text] [Related]
33. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy.
Verza FA; Das U; Fachin AL; Dimmock JR; Marins M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896
[TBL] [Abstract][Full Text] [Related]
34. The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells.
Maximov PY; Abderrahman B; Hawsawi YM; Chen Y; Foulds CE; Jain A; Malovannaya A; Fan P; Curpan RF; Han R; Fanning SW; Broom BM; Quintana Rincon DM; Greenland JA; Greene GL; Jordan VC
Mol Pharmacol; 2020 Jul; 98(1):24-37. PubMed ID: 32362585
[TBL] [Abstract][Full Text] [Related]
35. Acetylation of conserved DVL-1 lysines regulates its nuclear translocation and binding to gene promoters in triple-negative breast cancer.
Sharma M; Molehin D; Castro-Piedras I; Martinez EG; Pruitt K
Sci Rep; 2019 Nov; 9(1):16257. PubMed ID: 31700102
[TBL] [Abstract][Full Text] [Related]
36. Genomic Profiling of the Steroidogenic Acute Regulatory Protein in Breast Cancer: In Silico Assessments and a Mechanistic Perspective.
Manna PR; Ahmed AU; Yang S; Narasimhan M; Cohen-Tannoudji J; Slominski AT; Pruitt K
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31060224
[TBL] [Abstract][Full Text] [Related]
37. Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.
Girgert R; Emons G; Gründker C
Front Endocrinol (Lausanne); 2018; 9():781. PubMed ID: 30687231
[TBL] [Abstract][Full Text] [Related]
38. Early and late endothelial response in breast cancer metastasis in mice: simultaneous quantification of endothelial biomarkers using a mass spectrometry-based method.
Suraj J; Kurpińska A; Zakrzewska A; Sternak M; Stojak M; Jasztal A; Walczak M; Chlopicki S
Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30683749
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.
Manna PR; Ahmed AU; Vartak D; Molehin D; Pruitt K
Biochem Biophys Res Commun; 2019 Feb; 509(2):476-482. PubMed ID: 30595381
[TBL] [Abstract][Full Text] [Related]
40. DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells.
Castro-Piedras I; Sharma M; den Bakker M; Molehin D; Martinez EG; Vartak D; Pruitt WM; Deitrick J; Almodovar S; Pruitt K
Oncotarget; 2018 Nov; 9(86):35639-35654. PubMed ID: 30479694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
